Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FBETD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,913
Award facts
- Contract value 100% obligated
- $13,913.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,913.32 to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (30-count units) with a firm fixed price structure. This is a non-set-aside competitive award issued on June 16, 2025, with an ultimate completion date of June 17, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an expansive $999,999,999.00 prime vendor agreement valued through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency, primarily supporting military and veteran healthcare systems. The company's DLA prime vendor contract enables supply of a broad range of pharmaceutical products and medical commodities across multiple therapeutic domains to support Defense Health Agency and U.S. Coast Guard healthcare operations worldwide. This specific delivery order for BIKTARVY tablets reflects the company's ongoing role as a critical federal medical procurement vendor, with consistent competitively awarded delivery orders utilizing firm fixed pricing mechanisms.
Quick answers
Who was awarded contract SPE2DB25FBETD?
SPE2DB25FBETD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 16, 2025.
How much is contract SPE2DB25FBETD worth?
The government has obligated $13,913 on SPE2DB25FBETD.
Is contract SPE2DB25FBETD an order under another contract?
Yes. SPE2DB25FBETD is a delivery order under SPE2DB24D2100, an indefinite delivery contract.
Was contract SPE2DB25FBETD competed?
The extent of competition for SPE2DB25FBETD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award